Chor-Sang Chim
14PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Oct 06, 2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).Jin Seok Kim, Yang Song, Wei-Ying Jen
|Feb 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM.Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang
|Apr 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain.Hoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan
|Sep 03, 2021
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma.Chor Sang Chim, Shaji Kumar, Vincent Kai Chung Wong
|May 28, 2021
miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.Min Yue Zhang, Lu Qian Wang, Chor Sang Chim
|Oct 20, 2020
Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.Min Yue Zhang, George A Calin, Kit San Yuen
Pageof 3
Frequent Collaborators
3 joint publications
Yok-Lam Kwong
3 joint publications
Jorge J Castillo
3 joint publications
Anna Waszczuk-Gajda
2 joint publications
Shaji Kumar
2 joint publications
Kwan Yeung Wong
2 joint publications
Adam J Olszewski
2 joint publications
Yael Cohen
2 joint publications
Artur Jurczyszyn
1 joint publications
Je-Jung Lee
1 joint publications
Melissa Ooi Gaik Ming
